Found: 26
Select item for more details and to access through your institution.
Retinoblastoma Cell Growth In Vitro and Tumor Formation In Ovo —Influence of Different Culture Conditions.
- Published in:
- Methods & Protocols, 2022, v. 5, n. 2, p. N.PAG, doi. 10.3390/mps5020021
- By:
- Publication type:
- Article
ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12621, doi. 10.3390/ijms232012621
- By:
- Publication type:
- Article
p53, miR-34a and EMP1—Newly Identified Targets of TFF3 Signaling in Y79 Retinoblastoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 17, p. 4129, doi. 10.3390/ijms20174129
- By:
- Publication type:
- Article
Epigenetic Control of Trefoil Factor Family (TFF) Peptide Expression in Human Retinoblastoma Cell Lines.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2014, v. 34, n. 3, p. 1001, doi. 10.1159/000366316
- By:
- Publication type:
- Article
Evaluation of Chromosome 11p Imbalances in Aniridia and Wilms Tumor Patients.
- Published in:
- American Journal of Medical Genetics. Part A, 2013, v. 161A, n. 5, p. 958, doi. 10.1002/ajmg.a.35818
- By:
- Publication type:
- Article
α-Ketoglutarate supplementation and NAD+ modulation enhance metabolic rewiring and radiosensitization in SLC25A1 inhibited cancer cells.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01805-x
- By:
- Publication type:
- Article
Additive Effects of Retinoic Acid (RA) and Bone Morphogenetic Protein 4 (BMP-4) Apoptosis Signaling in Retinoblastoma Cell Lines.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0131467
- By:
- Publication type:
- Article
Gastric Inhibitory Polypeptide Receptor (GIPR) Overexpression Reduces the Tumorigenic Potential of Retinoblastoma Cells.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1656, doi. 10.3390/cancers16091656
- By:
- Publication type:
- Article
Trefoil Family Factor Peptide 1—A New Biomarker in Liquid Biopsies of Retinoblastoma under Therapy.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4828, doi. 10.3390/cancers15194828
- By:
- Publication type:
- Article
Novel Function of Cancer Stem Cell Marker ALDH1A3 in Glioblastoma: Pro-Angiogenesis through Paracrine PAI-1 and IL-8.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4422, doi. 10.3390/cancers15174422
- By:
- Publication type:
- Article
Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 60, doi. 10.3390/cancers13010060
- By:
- Publication type:
- Article
New retinoblastoma (RB) drug delivery approaches: anti‐tumor effect of atrial natriuretic peptide (ANP)‐conjugated hyaluronic‐acid‐coated gold nanoparticles for intraocular treatment of chemoresistant RB.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 832, doi. 10.1002/1878-0261.13587
- By:
- Publication type:
- Article
New retinoblastoma (RB) drug delivery approaches: anti‐tumor effect of atrial natriuretic peptide (ANP)‐conjugated hyaluronic‐acid‐coated gold nanoparticles for intraocular treatment of chemoresistant RB.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 4, p. 832, doi. 10.1002/1878-0261.13587
- By:
- Publication type:
- Article
Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 4, p. 957, doi. 10.1002/1878-0261.13054
- By:
- Publication type:
- Article
Chemotherapy and terminal skeletal muscle differentiation in <italic>WT1‐</italic>mutant Wilms tumors.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 4, p. 1359, doi. 10.1002/cam4.1379
- By:
- Publication type:
- Article
Trefoil factor family peptides - friends or foes?
- Published in:
- Biomolecular Concepts, 2015, v. 6, n. 5/6, p. 343, doi. 10.1515/bmc-2015-0020
- By:
- Publication type:
- Article
5-ALA-mediated fluorescence of musculoskeletal tumors in a chick chorio-allantoic membrane model: preclinical in vivo qualification analysis as a fluorescence-guided surgery agent in Orthopedic Oncology.
- Published in:
- Journal of Orthopaedic Surgery & Research, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13018-022-02931-x
- By:
- Publication type:
- Article
Evaluation of the Effect of Photodynamic Therapy on CAM-Grown Sarcomas.
- Published in:
- Bioengineering (Basel), 2023, v. 10, n. 4, p. 464, doi. 10.3390/bioengineering10040464
- By:
- Publication type:
- Article
Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 15, p. 3958, doi. 10.1093/hmg/ddu111
- By:
- Publication type:
- Article
Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.
- Published in:
- International Journal of Cancer, 2017, v. 141, n. 3, p. 549, doi. 10.1002/ijc.30768
- By:
- Publication type:
- Article
Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma.
- Published in:
- Journal of Oncology, 2023, p. 1, doi. 10.1155/2023/2270097
- By:
- Publication type:
- Article
Forced Trefoil Factor Family Peptide 3 (TFF3) Expression Reduces Growth, Viability, and Tumorigenicity of Human Retinoblastoma Cell Lines.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163025
- By:
- Publication type:
- Article
Re-characterization of established human retinoblastoma cell lines.
- Published in:
- Histochemistry & Cell Biology, 2015, v. 143, n. 3, p. 325, doi. 10.1007/s00418-014-1285-z
- By:
- Publication type:
- Article
Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.
- Published in:
- Human Molecular Genetics, 2010, v. 19, n. 9, p. 1651, doi. 10.1093/hmg/ddq042
- By:
- Publication type:
- Article
Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 8, p. 4572, doi. 10.3390/ijms25084572
- By:
- Publication type:
- Article
Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines.
- Published in:
- Oncology Reports, 2018, v. 39, n. 1, p. 160, doi. 10.3892/or.2017.6100
- By:
- Publication type:
- Article